MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >
Upcoming 2020 Webinars for MDS Patients & Caregivers

Upcoming 2020 Webinars for MDS Patients & Caregivers LIVING with MDS . The diagnosis of MDS is often unexpected and filled with both immediate and long-term challenges.  You probably have many questions.  Whether you are a newly diagnosed patient, a long-term survivor, or caregiver, our webinar series will have something for you.

Given the growing concerns surrounding COVID-19 and for the safety of our attendees, the MDS Foundation will be hosting a series of webinars in place of our in-person patient forums for the remainder of 2020. We will be collaborating with renowned hematology professionals who will be addressing key topics and questions you may have using language that is easy to understand in a 90-minute format that will include live Q&A opportunities for all participants.

Register now for our 8 webinars planned for this series. Led by top thought leaders in the field, you can be assured you are getting information you can trust.

  • June 13, 2020: Treatment of High Risk MDS and the Indication for Stem Cell Transplant @12 pm EDT
    Speaker:  Prapti Patel, MD; University of Texas Southwestern
    This webinar will provide an overview of high-risk MDS, secondary AML, and indication for stem cell transplant, focusing on strategies for patient management.  Risk assessment, treatment options, as well as resources for patients and caregivers will be discussed.  
    View Presentation
  • June 27, 2020:  Familial MDS @ 12 pm EDT
    Speaker:  Jane Churpek, MD, MS; UW Carbone Cancer Center, University of Wisconsin School of Medicine
    This webinar will provide an overview of familial MDS, focusing on whether MDS is hereditary and can you give MDS to loved ones.  Inherited genetic predisposition for developing MDS and congenital abnormalities will be discussed.  
    View Presentation Q&A
  • July 18, 2020:  Low-Risk MDS: Can we prevent progression? Updates from EHA 2020 will also be presented.  @12 pm EDT
    Speaker:  Casey L. O’Connell, MD; University of Southern California, Keck School of Medicine
    This webinar will provide an overview summarizing changes in the treatment landscape for patients with low-risk myelodysplastic syndromes. The concerns of low-risk MDS patients and their caregivers will be addressed. 
    View Presentation Q&A
  • July 25, 2020:  What is MDS? How Do We Determine Prognosis?  @ 12 pm EDT
    Speaker:  Jamile Shammo, MD; Rush University Medical Center
    This webinar will provide an overview of MDS and how prognosis is determined, focusing on the MDS subtypes and disease process of MDS.  Understanding the diagnosis of MDS,  details about the  various approaches to treatment, and answers to common questions will be discussed.  
    View Presentation Q&A
  • August 8, 2020:  MDS Therapies & Options in 2020 @12 pm EDT
    Speaker:  James M. Foran, MD, FRCPC; Mayo Clinic Cancer Center, Jacksonville, FL
    This webinar will provide an overview of the current treatment strategies for MDS patients. The latest promising clinical trials and research findings impacting the biology and treament of MDS patients will be discussed.  
    View Presentation
  • August 29, 2020:  Emerging Treatments for Low-Risk MDS @12 pm EDT
    Speaker:  Barry Skikne, MD, The University of Kansas Cancer Center
    This webinar will provide an overview on low-risk MDS focusing on strategies for patient management.  Details on the various approaches to treatment including new promising clinical trials and  answers to concerns of patients will be discussed. 
    View Presentation Q&A
  • September 26, 2020:  MDS Support Group Webinar @12 pm EDT
    Speaker:  Jean A. Ridgeway, DNP,APN,NP-C,AOCN
    MDS Foundation International Nurse Leadership Board
    This webinar will address all aspects of becoming a partner in your care.  Whether you are a patient or caregiver, you will be able to connect with others, gather ideas and learn about resources. 
    View Presentation
  • October 10, 2020: Stem Cell Transplant for MDS @12 pm EDT
    Speaker: Joseph P. McGuirk, D.O.
    University of Kansas Medical Center
    This webinar will provide an overview of the epidemiology of MDS. Risk Assessment, IPSS-R Prognostic Risk Categories, Allogeneic HCT will be discussed.
    View Presentation

Learn from experts about treatment therapies and strategies for Patients & Caregiver LIVING with MDS.

Thank you to Acceleron, Bristol-Myers Squibb, Jazz, Novartis, and Takeda for supporting these important events.

Review answers to commonly asked questions or get answers to your questions from an MDS expert